Menu

HIV Quickly Invades the Brain

The virus that causes AIDS can replicate and mutate in the brain as early as four months after initial infection, according to a new study.

Mar 30, 2015
Jenny Rood

NIAID/NIH, SETH PINCUS, ELIZABETH FISCHER, AUSTIN ATHMANHIV enters the brain early in the course of infection and begins to evolve separately from the blood-based viral population as early as 140 days after initial infection, according to a study published last week (March 26) in PLoS Pathogens.

Researchers from the University of North Carolina, Chapel Hill, the University of California, San Francisco, and Yale analyzed cerebral spinal fluid and blood from 72 HIV-positive patients who were not being treated with antiretroviral therapy (ART). The scientists found that 30 percent of the patients either had replicating viruses or signs of inflammation in their spinal fluid, and that these symptoms persisted for varying amounts of time in 16 percent of the patients, suggesting an ongoing infection.

The researchers also sequenced the viral genomes from approximately half of the patients. From five months after infection to the two-year end point of the study, 20 percent of those 33 patients had developed mutations in the population of virus residing in the brain that differed from the blood-based virus.

“The implication is that there’s a specific infection of the brain rather than HIV just being carried in the blood and passing through the brain,” study coauthor Serena Spudich of Yale University told The Atlantic. HIV is already known to cause cognitive impairment, leading to HIV-associated dementia in one-third of patients who are not on ART. A genetically distinct viral population in the brain could also make the disease more difficult to treat, since some medications may not be able to target an infection there.

“This shows that viral replication and inflammation can occur early in infection, with the concern being that the damage caused could be irreversible,” study coauthor Ronald Swanstrom of the University of North Carolina added in a statement, although future research will be needed to determine if the brain infection is truly untreatable.

 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening